External Collaborative Research Grants: Non-Small Cell Lung Cancer
Submission Deadline: 11/05/2026
Learn More
Evidence-Based Education on the Potential Impact of a Generic JAK Inhibitor on the Management of Rheumatologic Diseases
Submission Deadline: 05/21/2026
Learn More
Ulcerative Colitis- Medical Education Grants
Learn More
Plaque Psoriasis- Medical Education Grant
Learn More
Ankylosing Spondylitis Medical Education Grant
Learn More
Medical Education Grant: Polyarticular Juvenile Idiopathic Arthritis
Learn More
Medical Education Grant: Generalized Mysathenia Gravis
Learn More
Medical Education Grant: wAIHA – Warm Autoimmune Hemolytic Anemia
Learn More
Medical Education Grant: Multiple Myeloma
Learn More
Medical Education Grant: Non-Small Cell Lung Cancer
Learn More
Medical Education Grant: Bladder Cancer
Learn More
Medical Education Grant – Prostate Cancer
Learn More
Continuing Medical Education (Pulmonologists, Cardiologists, RPh, NPs/PAs, PCPs, Rheums
Learn More
Mood – Treatment Resistant Depression – Major Depressive Disorder with inadequate response to 2 or more antidepressants
Learn More
Mood – Targeting novel pathways in Depression
Learn More
Schizophrenia – Adults with Schizophrenia
Learn More
Abemaciclib (Verzenio) – LY2835219
Learn More
B-cell Activation Factor Receptor (BAFF-R) – LY4152199
Learn More
Fibroblast Growth Factor Receptor 3 (FGFR3) Inhibitor – LY3866288
Learn More
Folate Receptor Alpha (FRα) – LY4170156
Learn More
Investigator Initiated Trial: Colorectal Cancer with Fruquintinib
Learn More
Investigator Initiated Studies – ER+ Breast Cancer with Imlunestrant
Learn More
Investigator-Initiated study – Pre-clinical studies with KRAS G12D
Learn More
Investigator Initiated Study- Non-small cell lung cancer (NSCLC)
Learn More
Investigator Initiated Study – Oncology, non-compound specific
Learn More
Investigator Initiated Trials – Pre-clinical oncology
Learn More
Investigator Initiated Trial: Chronic lymphocytic leukemia (CLL) or Large Cell Lymphoma
Learn More